IMO Health leadership

Andrew Kanter, MD, MPH, FACMI, FAMIA

Senior Advisor

Dr. Andrew Kanter joined IMO Health in 1995 and serves as Senior Advisor to the Company. He provides thought leadership on IMO Health’s clinical roadmap and helps guide the Company in addressing key challenges within the industry. Andrew previously served as IMO Health’s Chief Medical Officer and has also held the roles of Chief Operating Officer and President.

Andrew is an Assistant Professor of Clinical Biomedical Informatics and Clinical Epidemiology at Columbia University and has served as the former Director of Health Information Systems/Medical Informatics for the Millennium Villages Project at the Earth Institute. He is a Fellow of the American College of Medical Informatics and the American Medical Informatics Association.

Andrew received both his MD and MPH from Harvard University in 1991 and completed a medical residency and chief residency in Internal Medicine at the University of Washington in Seattle from 1991–1995.

More from Andrew Kanter, MD

A lively discussion as our expert panel shares their experiences with the POMR.
Leading experts discuss the latest on how widespread genetic screening programs can be incorporated into routine care, allowing patients to identify future risks.
Increased interoperability in healthcare – specifically, the sharing of electronic health data between systems – can be an enormous help for clinicians. But as federal rules are put into action, clinicians may soon be facing too much of a good thing.
This white paper explores the necessary but unfortunate delays to implementation of the 21st Century Cures Act, which focuses on information sharing and interoperability in the United States.
As those administering the vaccines grapple with multiple moving parts, competing priorities, and the race against emerging virus variants; the need to capture, manage, and optimize inoculation data has come into sharp focus.
How the EHR has changed over the years and the work that still needs to be done to improve these tools to better help the clinicians who use them.
For NLP engines to be truly valuable, the concepts used to fuel them must contain a high level of specificity and be accurately mapped to standardized codes.
A recent article in Health Affairs explores five reasons why quality measurement is failing, and five steps to guide the US toward true quality care.
The COVID-19 pandemic has exposed a number of systemic problems hindering healthcare in the United States. Below, IMO’s Chief Medical Officer, Andrew S. Kanter, MD, discusses the impact of one such issue – the frequent failure to collect data that is fit for purposes beyond financial management.
August is National Wellness Month – the perfect time to tap into the wisdom and expertise of IMO’s Chief Medical Officer, Andrew S. Kanter, MD. Below, he shares advice and insights on his mindfulness practice, the sessions he leads at IMO, and how mindfulness aligns with the company’s culture and priorities.
As options for care delivery and health tracking become more complex, sources of patient information have become more abundant – and varied. While technology and analytics advancements have great promise for supporting this complexity, getting to meaningful insights ultimately begins with the quality of the underlying clinical patient data. As a result, the hospital and health system of the future must ensure that a patient’s relevant history is accurate, accessible, and organized in order to support informed care.
By allowing clinicians to “speak like clinicians,” clinical interface terminology, or CIT, is the crosslink between providers and the mountain of regulatory, billing, and analytic initiatives operating within the healthcare system.

Boost your ROI

Ready for a 10X ROI on your IMO solutions investment?